Tracking Your Progress: Which Metabolic Labs to Monitor on GLP-1 Therapy

Glucagon-like peptide-1 (GLP-1) receptor agonists have become a cornerstone for managing diabetes, obesity, and related conditions. As you embark on or continue GLP-1 therapy, keeping an eye on GLP-1 metabolic health markers helps ensure you're improving safely and effectively. Tracking these labs regularly not only measures progress but also detects potential side effects early.

Below is a straightforward guide to the key metabolic markers to monitor, what they tell you, and how often you might check them. Use this as a conversation starter with your healthcare provider, and remember: if you notice anything concerning, speak to a doctor right away.

---

1. Glycemic Control Markers

Maintaining healthy blood sugar is often the primary goal of GLP-1 therapy. Two tests give a clear picture:

• Hemoglobin A1c (HbA1c):

  • Reflects average blood sugar over the past 2–3 months.
  • GLP-1 drugs often lower HbA1c by 0.5–1.5%.
  • Check every 3–6 months once you're on a stable dose.

• Fasting Plasma Glucose (FPG):

  • Measures blood sugar after an 8-hour fast.
  • Useful for day-to-day adjustments.
  • Test every 3 months, or more if dose changes.

Together, these markers show how well your GLP-1 medication is controlling blood sugar and reducing risk of long-term complications.

---

2. Kidney Function Tests

GLP-1 agonists can affect kidney function, especially if you have preexisting kidney issues.

• Serum Creatinine & Estimated GFR (eGFR):

  • Creatinine levels rise when kidneys can't filter properly.
  • eGFR estimates overall kidney filtering capacity.
  • Check at baseline, then every 6–12 months.

• Urine Albumin-to-Creatinine Ratio (UACR):

  • Detects early kidney damage.
  • Recommended annually, or more often if levels rise.

Monitoring kidney markers ensures your treatment remains safe and lets you catch early signs of kidney stress.

---

3. Liver Enzymes

Some patients may experience mild increases in liver enzymes when starting or adjusting GLP-1 therapy.

• ALT (Alanine Aminotransferase) & AST (Aspartate Aminotransferase):

  • Elevated levels may signal liver irritation.
  • Check at baseline, 3 months after starting therapy, then every 6–12 months.

• Alkaline Phosphatase (ALP) & Bilirubin:

  • Provide additional context on liver and bile duct health.
  • Monitored alongside ALT/AST if there's a concern.

Keeping an eye on these markers helps catch rare liver issues before they become serious.

---

4. Lipid Profile

Improving metabolic health with GLP-1 therapy often leads to better cholesterol and triglyceride levels.

• Total Cholesterol, LDL-C, HDL-C, Triglycerides:
  • GLP-1 drugs can reduce triglycerides and LDL ("bad" cholesterol) while raising HDL ("good" cholesterol).
  • Check at baseline and every 6–12 months.

A healthier lipid profile lowers cardiovascular risk, a major benefit of optimized GLP-1 metabolic health markers.

---

5. Thyroid Function

Though uncommon, some GLP-1 medications have been linked to thyroid changes. Monitoring thyroid health is particularly important if you have a personal or family history of thyroid disease.

• TSH (Thyroid-Stimulating Hormone):

  • First-line test for thyroid function.
  • Check at baseline and annually if you have no thyroid history.

• Free T4 (Thyroxine):

  • Measured if TSH is abnormal to pinpoint hypo- or hyperthyroidism.

Early detection helps manage potential thyroid side effects promptly.

---

6. Nutritional & Electrolyte Markers

GLP-1 therapies often lead to reduced appetite and weight loss. While beneficial, significant weight change can affect nutrient levels and electrolytes.

• Vitamin B12:

  • Low levels can cause fatigue, anemia, or neuropathy.
  • Check annually, especially if you take metformin as well.

• Electrolytes (Sodium, Potassium, Magnesium):

  • Ensure proper muscle, nerve, and heart function.
  • Test every 6–12 months or if you experience dizziness, cramps, or palpitations.

• Albumin & Total Protein:

  • Reflect overall nutritional status.
  • Checked if you're losing weight rapidly or notice swelling.

By tracking these markers, you safeguard against unintended nutrient deficiencies.

---

7. Inflammatory & Hormonal Markers (Optional)

For a deeper dive into metabolic health, some clinicians order:

• High-Sensitivity C-Reactive Protein (hs-CRP):

  • Indicates overall inflammation.
  • May decrease with better glycemic control and weight loss.

• Adiponectin & Leptin:

  • Hormones linked to appetite and fat distribution.
  • Research tools more than routine tests, but can offer insight in complex cases.

While not essential for everyone, these markers can round out your understanding of therapy benefits.

---

Putting It All Together

Here's a quick reference list of key GLP-1 metabolic health markers to monitor:

• Glycemic Control: HbA1c, Fasting Plasma Glucose
• Kidney Function: Serum Creatinine, eGFR, Urine Albumin/Creatinine Ratio
• Liver Enzymes: ALT, AST, ALP, Bilirubin
• Lipids: Total Cholesterol, LDL-C, HDL-C, Triglycerides
• Thyroid: TSH, Free T4
• Nutrition & Electrolytes: Vitamin B12, Sodium, Potassium, Magnesium, Albumin
• Inflammation/Hormones (if indicated): hs-CRP, Adiponectin, Leptin

Most labs are checked at baseline, then every 3–12 months depending on your health status and therapy stability. Your doctor will tailor the schedule based on your individual risk factors and response.

---

Empower Yourself with Ongoing Monitoring

Regular lab checks keep you informed about how well GLP-1 therapy works and reveal any emerging concerns. Understanding GLP-1 metabolic health markers gives you confidence that you're on the right track.

If you ever experience new symptoms—like persistent nausea, unexplained fatigue, swelling, or mood changes—you can use Ubie's free Medically approved LLM Symptom Checker Chat Bot to get immediate, AI-powered guidance on whether you should seek urgent care.

---

Final Thoughts

Tracking your labs is an essential part of safe, effective GLP-1 therapy. Share your results with your healthcare team, ask questions if anything looks off, and adjust testing frequency as needed.

Most importantly, always speak to a doctor about any symptoms that could be life threatening or serious. Regular monitoring paired with open communication ensures you gain the full benefits of GLP-1 therapy without unnecessary risks.